Looking back on the achievements of the companies we have worked with, we have to conclude that the sense of a job well done takes a lot of beating.
Fonderie Valdelsane
www.fonderievaldelsane.com
Brief description
In portfolio since October 2017, Fonderie Valdersane (“FV”) is the global leader producer of moulds for the glass packaging industry. Founded in 1961, FV operates its plant located in Tuscany.
Investment Rationale
- Glass packaging industry stability/growth
- Superior operating process/production
- Longstanding relationships with key customers
- Room for expanding small customer base
- Unique customer service
Value Creation
- Support market strategies by customer/product/geography
- Implement financial reporting and control systems
- Explore external growth opportunities
Status
- In portfolio
Sanitex
www.sanitex.net
Brief Description
In portfolio since February 2022, Sanitex is an established player in the northwest of Italy, supplying public and private customers with medical devices for interventional cardiology, cardiac surgery, vascular surgery, and others (general surgery, oncology, anesthesia and resuscitation).
Investment Rationale
- Leadership in the geographical area
- Balanced portfolio inclusive of innovative and high potential products
- Focus on therapeutical areas
- Strong team
- Entry point for industry consolidation
Value creation
- Empowering therapeutical areas portfolio with high tech/innovative products
- Extend the servicing business
- Geographical expansion
- Innovative product screening, investing and ”go to market” services
- Global view perspective through investor’s network and high profile scientific committee
- Reporting-control system
- Some complementary therapeutic areas integration
Status
- In portfolio
MPA Technical Devices
www.mpaitaly.com
Brief Description
In portfolio since July 2023, MPA Technical Devices is a leading company in the production of precision filling devices mainly for the pharmaceutical, cosmetic and food & beverage industries. The experience gained over the years has allowed the company to design and manufacture high quality technical devices tailored to customers’ needs, which include 16 of the 20 largest global Big Pharma.
Investment Rationale
- Leadership position in Italy and abroad in manufacturing for the pharmaceutical sector
- Counter-cyclical reference market
- High barriers to entry due to the high specialization of certified processes
- Motivated, experienced and future-oriented management team
- High margins and high cash generation
Value creation
- Focus on R&D, development of new products and innovative solutions
- Geographical expansion with focus on USA
- Strengthening of the sales area and after-sales customer service
- Implementation of the reporting and control system
Status
- In portfolio